Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |